Global Methyl Salicylate Patches Market Size, Share, and Trends Analysis Report, By Application (Arthritis, Sprains, and Backaches) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Forecast (2022-2028)

The methyl salicylate patches market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Methyl salicylate patches are a nonsteroidal anti-inflammatory medicine (NSAID) that acts by decreasing inflammation and pain-causing hormones in the body. Minor muscle/joint aches and pains are treated with methyl salicylate (such as arthritis, backache, sprains). Menthol and methyl salicylate function by cooling and then warming the skin. The most extensively utilized therapeutic family of analgesic chemicals are NSAIDs, which are authorized for use in alleviating post-extraction pain. Methyl salicylate patches sodium is a regularly prescribed NSAID with anti-inflammatory, analgesic, and antipyretic properties. Methyl salicylate transdermal patches are placed directly in the region of discomfort to provide brief relief from mild muscular and joint aches and pains. Due to its once-daily administration and lower incidence of systemic side effects, transdermal methyl salicylate patches are more effective than methyl salicylate pills. The major factor driving the growth of the market includes the rising prevalence of chronic pain disease. According to the CDC, in 2019, 20.4% of people reported chronic pain, and 7.4% of adults had chronic pain that often-hindered life or job activities. Chronic pain and high-impact chronic pain both rose with age, with those aged 65 and above experiencing the most.

The global methyl salicylate patches market is segmented based on application and distribution channels. Based on application, the market is sub-segmented into arthritis, sprains, and backaches. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Among these distribution channels, the retail pharmacy segment is expected to propel the growth of the market due to the increasing purchase of these patches from retail pharmacies for daily use, especially to cure sprains.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Cadila Healthcare Ltd., GlaxoSmithKline PLC, Hisamitsu Pharmaceutical Co. Inc., Novartis International AG, and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Methyl Salicylate Patches Market Report by Segment

By Application

• Arthritis
• Sprains
• Backaches

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Methyl Salicylate Patches Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa